Similar Articles
551 Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
552 Multiple primary malignancies – hepatocellular carcinoma combined with splenic lymphoma: A case report
553 Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
554 Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
555 Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study
556 Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
557 Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
558 Liver magnetic resonance imaging for evaluation of response to treatment after stereotactic body radiation therapy of hepatocellular carcinoma
559 Liver transplantation with simultaneous splenectomy increases risk of cancer development and mortality in hepatocellular carcinoma patients
560 Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA